Authors:
Turner, J
Howe, RA
Wootton, M
Bowker, KE
Holt, HA
Salisbury, V
Bennett, PM
Walsh, TR
MacGowan, AP
Citation: J. Turner et al., The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model, J ANTIMICRO, 48(5), 2001, pp. 727-730
Authors:
Wootton, M
Howe, RA
Hillman, R
Walsh, TR
Bennett, PM
MacGowan, AP
Citation: M. Wootton et al., A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital (vol 47, pg 399, 2001), J ANTIMICRO, 48(1), 2001, pp. 161-161
Authors:
Wootton, M
Howe, RA
Hillman, R
Walsh, TR
Bennett, PM
MacGowan, AP
Citation: M. Wootton et al., A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital, J ANTIMICRO, 47(4), 2001, pp. 399-403
Authors:
Walsh, TR
Bolmstrom, A
Qwarnstrom, A
Ho, P
Wootton, M
Howe, RA
MacGowan, AP
Diekema, D
Citation: Tr. Walsh et al., Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides, J CLIN MICR, 39(7), 2001, pp. 2439-2444
Authors:
MacGowan, AP
Rogers, CA
Holt, HA
Wootton, M
Bowker, KE
Citation: Ap. Macgowan et al., Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an invitro pharmacokinetic model of infection, ANTIM AG CH, 45(10), 2001, pp. 2916-2921
Authors:
Baird, JW
Ryan, KM
Hayes, I
Hampson, L
Heyworth, CM
Clark, A
Wootton, M
Ansell, JD
Menzel, U
Hole, N
Graham, GJ
Citation: Jw. Baird et al., Differentiating embryonal stem cells are a rich source of haemopoietic gene products and suggest erythroid preconditioning of primitive haemopoietic stem cells, J BIOL CHEM, 276(12), 2001, pp. 9189-9198
Authors:
Siriamornpun, S
Wootton, M
Cox, JM
Bekes, F
Wrigley, CW
Citation: S. Siriamornpun et al., Capillary electrophoresis of wheat gliadin proteins and its potential for wheat varietal identification using pattern matching software, AUST J AGR, 52(8), 2001, pp. 839-843
Authors:
MacGowan, A
Rogers, C
Holt, HA
Wootton, M
Bowker, K
Citation: A. Macgowan et al., Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin, J ANTIMICRO, 46(1), 2000, pp. 73-78
Authors:
MacGowan, AP
Bowker, KE
Wootton, M
Holt, HA
Citation: Ap. Macgowan et al., Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and streptococci of Lancefield Groups A and G, J ANTIMICRO, 44(6), 1999, pp. 761-766
Authors:
Wootton, M
Bowker, KE
Janowska, A
Holt, HA
MacGowan, AP
Citation: M. Wootton et al., In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci, J ANTIMICRO, 44(4), 1999, pp. 445-453
Citation: Ap. Macgowan et al., The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility, J ANTIMICRO, 43(3), 1999, pp. 345-349
Authors:
Howe, RA
Wootton, M
Bennet, PM
MacGowan, AP
Walsh, TR
Citation: Ra. Howe et al., Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility, J CLIN MICR, 37(9), 1999, pp. 3068-3071
Authors:
MacGowan, AP
Bowker, KE
Wootton, M
Holt, HA
Citation: Ap. Macgowan et al., Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infection, ANTIM AG CH, 43(7), 1999, pp. 1560-1564